Serious adverse events after cessation of nucleos(t)ide analogues in individuals with chronic hepatitis B: A systematic review and meta-analysis.
JHEP Rep
; 5(1): 100617, 2023 Jan.
Article
in En
| MEDLINE
| ID: mdl-36466989
ALT, alanine transaminase; CHB, chronic hepatitis B; Chronic hepatitis B; ETV, entecavir; HBV, hepatitis B virus; HBeAg, hepatitis B e-antigen; HBsAg, hepatitis B surface antigen; NUC, nucleos(t)ide analogues; PT, prothrombin time; TDF, tenofovir disoproxil fumarate; finite therapy; nucleos(t)ide analogue; outcome research
Full text:
1
Database:
MEDLINE
Type of study:
Systematic_reviews
Language:
En
Journal:
JHEP Rep
Year:
2023
Type:
Article
Affiliation country:
Taiwan